title: MEN1 is a melanoma tumor suppressor that preserves genomic integrity by stimulating transcription of genes that promote homologous recombination-directed DNA repair.
abstract: Multiple endocrine neoplasia type 1 is a familial cancer syndrome resulting from loss-of-function mutations in the MEN1 gene. We previously identified the tumor suppressor MEN1 as a gene required for oncogene-induced senescence in melanocytes, raising the possibility that MEN1 is a melanoma tumor suppressor. Here we show that MEN1 expression is lost in a high percentage of human melanomas and melanoma cell lines. We find that melanocytes depleted of MEN1 are deficient in homologous recombination (HR)-directed DNA repair, which is accompanied by increased nonhomologous end-joining activity. Following DNA damage, MEN1 levels increase as a result of phosphorylation by the DNA damage kinase ATM/ATR. Most importantly, we show that MEN1 functions by directly stimulating the transcription of several genes, including BRCA1, RAD51, and RAD51AP1, that encode proteins involved in HR. MEN1 and its coactivator, the mixed-lineage leukemia histone methyltransferase, are recruited to the BRCA1, RAD51, and RAD51AP1 promoters by estrogen receptor 1, resulting in increased histone H3-lysine 4 trimethylation and transcription. Collectively, our results indicate that MEN1 is a melanoma tumor suppressor that functions by stimulating the transcription of genes involved in HR-directed DNA repair.
authors: Howard Hughes Medical Institute, Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
authors: Minggang
authors: M
authors: Fang
authors: Fen
authors: F
authors: Xia
authors: Meera
authors: M
authors: Mahalingam
authors: Ching-Man
authors: CM
authors: Virbasius
authors: Narendra
authors: N
authors: Wajapeyee
authors: Michael R
authors: MR
authors: Green
mesh_terms: D064007:Ataxia Telangiectasia Mutated Proteins; D019313:BRCA1 Protein / Q000235:genetics; D018797:Cell Cycle Proteins / Q000235:genetics / Q000378:metabolism; D002460:Cell Line; D045744:Cell Line, Tumor; D053903:DNA Breaks, Double-Stranded; D004249:DNA Damage / Q000235:genetics; D059766:DNA End-Joining Repair / Q000235:genetics; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism; D047628:Estrogen Receptor alpha / Q000235:genetics / Q000378:metabolism; D005786:Gene Expression Regulation; D015972:Gene Expression Regulation, Neoplastic; D011495:Histone-Lysine N-Methyltransferase; D006801:Humans; D008545:Melanoma / Q000235:genetics*; D051788:Myeloid-Lymphoid Leukemia Protein / Q000235:genetics / Q000378:metabolism; D010766:Phosphorylation; D011401:Promoter Regions, Genetic; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000378:metabolism*; D016601:RNA-Binding Proteins; D051135:Rad51 Recombinase / Q000235:genetics / Q000378:metabolism; D059767:Recombinational DNA Repair / Q000235:genetics*; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000378:metabolism
chemical_list: D019313:BRCA1 Protein; C492913:BRCA1 protein, human; D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; C506487:ESR1 protein, human; D047628:Estrogen Receptor alpha; C497422:KMT2A protein, human; C105373:MEN1 protein, human; D011518:Proto-Oncogene Proteins; C110410:RAD51AP1 protein, human; D016601:RNA-Binding Proteins; D025521:Tumor Suppressor Proteins; D051788:Myeloid-Lymphoid Leukemia Protein; D011495:Histone-Lysine N-Methyltransferase; C576324:ATM protein, human; C576597:ATR protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; D017346:Protein Serine-Threonine Kinases; C495153:RAD51 protein, human; D051135:Rad51 Recombinase
references: Nature. 2007 Oct 25;449(7165):1073-7
references: 17960246
references: Mol Cell Biol. 2004 Jul;24(13):5639-49
references: 15199122
references: Cancer Res. 2003 Oct 1;63(19):6135-9
references: 14559791
references: Nat Chem Biol. 2006 Jul;2(7):369-74
references: 16767085
references: Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1630-4
references: 9465067
references: Oncogene. 2001 Aug 16;20(36):4917-25
references: 11526476
references: Science. 2005 Aug 5;309(5736):886-7
references: 16081723
references: Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14659-64
references: 16195383
references: PLoS Genet. 2006 Apr;2(4):e51
references: 16604156
references: Cell Res. 2008 Jan;18(1):134-47
references: 18157161
references: FEBS Lett. 2010 Nov 19;584(22):4531-6
references: 20969866
references: Nat Rev Mol Cell Biol. 2010 Mar;11(3):196-207
references: 20177395
references: J Biol Chem. 2009 Oct 30;284(44):30565-73
references: 19744924
references: Biochim Biophys Acta. 2006 Dec;1766(2):205-16
references: 16919882
references: PLoS One. 2011 Jan 14;6(1):e16119
references: 21264250
references: DNA Repair (Amst). 2009 Aug 6;8(8):944-52
references: 19608464
references: Nat Rev Cancer. 2008 Dec;8(12):957-67
references: 19005492
references: DNA Repair (Amst). 2006 Sep 8;5(9-10):1021-9
references: 16807135
references: Science. 2007 May 25;316(5828):1160-6
references: 17525332
references: Mol Biol Cell. 2008 Apr;19(4):1693-705
references: 18256278
references: Mol Cell. 2004 Feb 27;13(4):587-97
references: 14992727
references: Cancer Res. 2003 Jul 15;63(14):4204-10
references: 12874027
references: Science. 1998 Sep 11;281(5383):1677-9
references: 9733515
references: Hum Mol Genet. 2004 Oct 15;13(20):2399-408
references: 15333582
references: Mol Cell. 2009 Jul 31;35(2):228-39
references: 19647519
references: Cancer Res. 2006 May 1;66(9):4929-35
references: 16651450
references: Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3837-42
references: 11274402
references: PLoS Biol. 2005 Feb;3(2):e44
references: 15719058
references: J Clin Endocrinol Metab. 2001 Mar;86(3):1355-61
references: 11238532
references: Adv Cancer Res. 2010;108:73-112
references: 21034966
references: Trends Biochem Sci. 2006 Jul;31(7):402-10
references: 16774833
references: J Clin Oncol. 2011 Dec 1;29(34):e827-9
references: 22025144
references: N Engl J Med. 2003 Nov 20;349(21):2042-54
references: 14627790
references: Nucleic Acids Res. 1996 Oct 15;24(20):4084-91
references: 8918816
references: Nucleic Acids Res. 1999 Jul 1;27(13):2655-61
references: 10373582
references: Biomed Pharmacother. 2000 Jun;54 Suppl 1:187s-190s
references: 10915021
references: Cell. 2008 Feb 8;132(3):363-74
references: 18267069
references: J Invest Dermatol. 2013 May;133(5):1294-301
references: 23303449
references: Cancer Lett. 2003 Jan 10;189(1):1-10
references: 12445671
references: Nat Cell Biol. 2005 Feb;7(2):195-201
references: 15665856
references: Biosci Rep. 2012 Aug;32(4):361-74
references: 22762204
references: J Intern Med. 2009 Jul;266(1):53-9
references: 19522825
references: J Natl Cancer Inst. 2004 Nov 17;96(22):1659-68
references: 15547178
references: Cancer Res. 1991 Aug 1;51(15):3867-73
references: 1855205
references: Genome Res. 2012 Nov;22(11):2153-62
references: 23019147
references: Hum Mol Genet. 2004 Jan 15;13(2):203-12
references: 14645207
references: Int J Cancer. 2000 Aug 15;87(4):463-7
references: 10918183
references: Nat Rev Mol Cell Biol. 2003 Sep;4(9):712-20
references: 14506474